A literature search was conducted using the PubMed, Embase and Cochrane Library databases to collect trials related to relapsed/refractory diffuse large B-cell lymphoma (DLBCL) with a search deadline of Jan 25, 2021.

A total of 58 studies with 68 treatment arms and 3124 subjects were included in the analysis.